Pasithea Therapeutics Corp. KTTAW
KTTAW
Pasithea Therapeutics Corp. COEP
Coeptis Therapeutics, Inc. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares NKGN
NKGen Biotech, Inc. Common Stock SYRS
Syros Pharmaceuticals, Inc. VRPX
Virpax Pharmaceuticals, Inc. MSPR
MSP Recovery, Inc. SLXNW
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. AKTX
Akari Therapeutics, Plc
Pasithea Therapeutics Corp. COEP
Coeptis Therapeutics, Inc. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares NKGN
NKGen Biotech, Inc. Common Stock SYRS
Syros Pharmaceuticals, Inc. VRPX
Virpax Pharmaceuticals, Inc. MSPR
MSP Recovery, Inc. SLXNW
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. AKTX
Akari Therapeutics, Plc
Performance
| Periode | KTTAW | COEP | NUVO | NKGN | SYRS | VRPX | MSPR | SLXNW | REVB | AKTX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -38.69 % | 53.80 % | 8 400.00 % | -84.38 % | -98.51 % | -91.80 % | -93.58 % | -23.72 % | -86.04 % | -33.89 % |
| YTD | -51.39 % | 160.24 % | 8 400.00 % | -97.11 % | -99.83 % | -99.78 % | -94.49 % | 53.78 % | -95.91 % | -33.89 % |
| 1Y | -43.26 % | 286.43 % | -83.50 % | -97.14 % | -99.98 % | -99.86 % | -94.22 % | -3.50 % | -96.84 % | -63.81 % |
| 3Y | -82.32 % | -92.48 % | -97.54 % | -99.65 % | -99.99 % | -99.99 % | -94.22 % | -77.29 % | -99.99 % | -91.84 % |
| 5Y | -98.60 % | -92.23 % | -97.54 % | -99.65 % | -100.00 % | -100.00 % | -94.22 % | -77.29 % | -100.00 % | -97.67 % |
| 10Y | -98.60 % | -92.23 % | -97.54 % | -99.65 % | -100.00 % | -100.00 % | -94.22 % | -77.29 % | -100.00 % | -99.78 % |
| From the beginning | -98.60 % | -92.23 % | -97.54 % | -99.65 % | -100.00 % | -100.00 % | -94.22 % | -77.29 % | -100.00 % | -99.75 % |